Verily Shutters Medical Device Division, Lays Off Staff — Refocuses on AI & Data
Verily Shutters Medical Device Division, Lays Off Staff — Refocuses on AI & Data Alphabet’s life-sciences arm Verily has closed its medical-device division and laid off staff as part of a strategic shift to concentrate on precision health, data and AI, according to an internal memo reported by news outlets. CEO Stephen Gillett highlighted Verily’s contributions — for example, the Dexcom G7 continuous glucose monitor and the Stargazer VNRC screening program — but said the company will now prioritize its core mission in data and AI-driven healthcare. Key points: Verily is discontinuing manufacturing of medical devices and will no longer support those products going forward. The exact number of employees affected was not disclosed in the memo. The move aligns with Alphabet’s broader shift toward AI and data infrastructure following…